iifl-logo-icon 1

Par Drugs & Chemicals Ltd Share Price

246.2
(1.69%)
Sep 18, 2024|09:39:54 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open242.1
  • Day's High247.95
  • 52 Wk High325
  • Prev. Close242.1
  • Day's Low242.1
  • 52 Wk Low 180
  • Turnover (lac)15.32
  • P/E20.45
  • Face Value10
  • Book Value71.65
  • EPS11.84
  • Mkt. Cap (Cr.)302.94
  • Div. Yield0
View All Historical Data
No Records Found

Par Drugs & Chemicals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

242.1

Prev. Close

242.1

Turnover(Lac.)

15.32

Day's High

247.95

Day's Low

242.1

52 Week's High

325

52 Week's Low

180

Book Value

71.65

Face Value

10

Mkt Cap (₹ Cr.)

302.94

P/E

20.45

EPS

11.84

Divi. Yield

0

Par Drugs & Chemicals Ltd Corporate Action

17 Aug 2024

12:00 AM

BookCloser

arrow

9 Aug 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

17 Aug 2023

12:00 AM

AGM

Announcement Date: 17 Aug, 2023

arrow

Par Drugs & Chemicals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Par Drugs & Chemicals Ltd SHAREHOLDING SNAPSHOT

18 Sep, 2024|10:22 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.20%

Foreign: 0.00%

Indian: 74.20%

Non-Promoter- 0.32%

Institutions: 0.32%

Non-Institutions: 25.46%

Custodian: 0.00%

Share Price

Par Drugs & Chemicals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

12.3

12.3

12.3

6.15

Preference Capital

0

0

0

0

Reserves

73.33

58.93

47.57

46.06

Net Worth

85.63

71.23

59.87

52.21

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017

Revenue

60.75

55.84

48.76

yoy growth (%)

8.77

14.52

Raw materials

-21.87

-23.65

-21.06

As % of sales

36.01

42.35

43.2

Employee costs

-3.97

-4.11

-3.18

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017

Profit before tax

12.74

5.99

3.26

Depreciation

-2.81

-2.76

-2.81

Tax paid

-3.11

-1.22

-1.51

Working capital

14.37

10.27

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2017

Growth matrix (%)

Revenue growth

8.77

14.52

Op profit growth

69.47

10.59

EBIT growth

97.21

17.67

Net profit growth

143.67

171.62

View Ratios

No Record Found

Par Drugs & Chemicals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,866.1

160.854,47,691.91237.820.724,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,452.2

87.171,44,798.514300.552,063507.93

Cipla Ltd

CIPLA

1,671.8

33.981,34,956.561,055.940.783,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,453.25

77.721,16,815.974690.812,394201.77

Zydus Lifesciences Ltd

ZYDUSLIFE

1,110.95

25.581,11,727.191,700.80.274,035.4156.19

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Par Drugs & Chemicals Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director

FALGUN VALLABHBHAI SAVANI

Executive Director & CEO

JIGNESHBHAI VALLABHBHAI SAVANI

WTD & Executive Director

GHANSHAYAMBHAI BHAGVANBHAI SAVANI

Non Executive Director

Nayna Jignesh Savani

Independent Non Exe. Director

Krishna Mitulbhai Shah

Independent Non Exe. Director

Kajal Chintanbhai Vaghani

Independent Non Exe. Director

Pravin Manjibhai Bhayani

Independent Non Exe. Director

Bintal Bhaveshkumar Shah

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name was changed to Par Drugs and Chemicals Limited on 5 November 2018.The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as bulk drugs or bulk actives are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Tauru
Read More

Company FAQs

What is the Par Drugs & Chemicals Ltd share price today?

Down Arrow

The Par Drugs & Chemicals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹246.2 today.

What is the Market Cap of Par Drugs & Chemicals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Par Drugs & Chemicals Ltd is ₹302.94 Cr. as of 18 Sep ‘24

What is the PE and PB ratio of Par Drugs & Chemicals Ltd?

Down Arrow

The PE and PB ratios of Par Drugs & Chemicals Ltd is 20.45 and 3.48 as of 18 Sep ‘24

What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Par Drugs & Chemicals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Par Drugs & Chemicals Ltd is ₹180 and ₹325 as of 18 Sep ‘24

What is the CAGR of Par Drugs & Chemicals Ltd?

Down Arrow

Par Drugs & Chemicals Ltd's CAGR for 5 Years at 60.40%, 3 Years at 17.30%, 1 Year at 32.26%, 6 Month at 16.12%, 3 Month at 7.01% and 1 Month at 1.69%.

What is the shareholding pattern of Par Drugs & Chemicals Ltd?

Down Arrow

The shareholding pattern of Par Drugs & Chemicals Ltd is as follows:
Promoters - 74.21 %
Institutions - 0.32 %
Public - 25.47 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp